Progenics Pharmaceuticals has entered a collaboration with Veteran Affairs Greater Los Angeles Healthcare System (VAGLAHS) to support the development of new machine learning tools ... Read more
The U.S. Food and Drug Administration (FDA) has approved Nubeqa (darolutamide) tablets to treat ...
Invitae has launched a free genetic testing program to help connect prostate cancer patients ...
ADT Linked to Higher Alzheimer’s and Dementia Risk in Older Prostate Cancer Patients, Study SuggestsMen with prostate cancer who undergo treatment with androgen deprivation therapy (ADT) — a ...
PyL, a new imaging agent for positron emission topography (PET) scans, can accurately detect ...
Subscribe to our mailing list
Get regular updates delivered to your email box.
Thanks! Please check your email for a confirmation email.
Two treatment approaches — Zytiga (abiraterone acetate) plus prednisolone (AAP) or Taxotere (docetaxel) — provided patients with high-risk prostate cancer similar benefits when added to standard hormone deprivation therapy, according to data recently presented at the European ... Read more